162 related articles for article (PubMed ID: 23372428)
1. Detection of hypermethylated spastic paraplegia-20 in stool samples of patients with colorectal cancer.
Zhang H; Song YC; Dang CX
Int J Med Sci; 2013; 10(3):230-4. PubMed ID: 23372428
[TBL] [Abstract][Full Text] [Related]
2. Detection of hypermethylated fibrillin-1 in the stool samples of colorectal cancer patients.
Guo Q; Song Y; Zhang H; Wu X; Xia P; Dang C
Med Oncol; 2013 Dec; 30(4):695. PubMed ID: 23963856
[TBL] [Abstract][Full Text] [Related]
3. SPG20, a novel biomarker for early detection of colorectal cancer, encodes a regulator of cytokinesis.
Lind GE; Raiborg C; Danielsen SA; Rognum TO; Thiis-Evensen E; Hoff G; Nesbakken A; Stenmark H; Lothe RA
Oncogene; 2011 Sep; 30(37):3967-78. PubMed ID: 21499309
[TBL] [Abstract][Full Text] [Related]
4. Detection of aberrant hypermethylated spastic paraplegia-20 as a potential biomarker and prognostic factor in gastric cancer.
Zhang H; Song Y; Xia P; Cheng Y; Guo Q; Diao D; Wang W; Wu X; Liu D; Dang C
Med Oncol; 2014 Feb; 31(2):830. PubMed ID: 24381142
[TBL] [Abstract][Full Text] [Related]
5. Novel methylation panel for the early detection of colorectal tumors in stool DNA.
Azuara D; Rodriguez-Moranta F; de Oca J; Soriano-Izquierdo A; Mora J; Guardiola J; Biondo S; Blanco I; Peinado MA; Moreno V; Esteller M; Capellá G
Clin Colorectal Cancer; 2010 Jul; 9(3):168-76. PubMed ID: 20643622
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylated DNA as a biomarker for colorectal cancer: a systematic review.
Rasmussen SL; Krarup HB; Sunesen KG; Pedersen IS; Madsen PH; Thorlacius-Ussing O
Colorectal Dis; 2016 Jun; 18(6):549-61. PubMed ID: 26998585
[TBL] [Abstract][Full Text] [Related]
7. Quantitative detection of SRY-Box 21 (
Moradi K; Babaei E; Hosseinpour Feizi MA; Safaralizadeh R; Rezvani N
Indian J Cancer; 2021; 58(2):217-224. PubMed ID: 33402569
[TBL] [Abstract][Full Text] [Related]
8. Stool methylation-specific polymerase chain reaction assay for the detection of colorectal neoplasia in Korean patients.
Baek YH; Chang E; Kim YJ; Kim BK; Sohn JH; Park DI
Dis Colon Rectum; 2009 Aug; 52(8):1452-9; discussion 1459-63. PubMed ID: 19617759
[TBL] [Abstract][Full Text] [Related]
9.
Liu L; Liu C; Fotouhi O; Fan Y; Wang K; Xia C; Shi B; Zhang G; Wang K; Kong F; Larsson C; Hu S; Xu D
Oncologist; 2017 Oct; 22(10):1178-1188. PubMed ID: 28754720
[TBL] [Abstract][Full Text] [Related]
10. DNA stool test for colorectal cancer: hypermethylation of the secreted frizzled-related protein-1 gene.
Zhang W; Bauer M; Croner RS; Pelz JO; Lodygin D; Hermeking H; Stürzl M; Hohenberger W; Matzel KE
Dis Colon Rectum; 2007 Oct; 50(10):1618-26; discussion 1626-7. PubMed ID: 17762966
[TBL] [Abstract][Full Text] [Related]
11. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
12. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer.
Lenhard K; Bommer GT; Asutay S; Schauer R; Brabletz T; Göke B; Lamerz R; Kolligs FT
Clin Gastroenterol Hepatol; 2005 Feb; 3(2):142-9. PubMed ID: 15704048
[TBL] [Abstract][Full Text] [Related]
13. Detection of SNCA and FBN1 methylation in the stool as a biomarker for colorectal cancer.
Li WH; Zhang H; Guo Q; Wu XD; Xu ZS; Dang CX; Xia P; Song YC
Dis Markers; 2015; 2015():657570. PubMed ID: 25802477
[TBL] [Abstract][Full Text] [Related]
14. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
15. Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
Bosch LJ; Mongera S; Terhaar Sive Droste JS; Oort FA; van Turenhout ST; Penning MT; Louwagie J; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cell Oncol (Dordr); 2012 Aug; 35(4):309-15. PubMed ID: 22821210
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
17. High-resolution melting assay (HRMA) is a simple and sensitive stool-based DNA Test for the detection of mutations in colorectal neoplasms.
Li BS; Wang XY; Xu AG; Ma FL; Ma QY; Li Z; Liu JH; Gan AH; Yu ZJ; Zhang XH; Jiang B
Clin Colorectal Cancer; 2012 Dec; 11(4):280-90. PubMed ID: 22609129
[TBL] [Abstract][Full Text] [Related]
18. Stool-based DNA testing, a new noninvasive method for colorectal cancer screening, the first report from Iran.
Abbaszadegan MR; Tavasoli A; Velayati A; Sima HR; Vosooghinia H; Farzadnia M; Asadzedeh H; Gholamin M; Dadkhah E; Aarabi A
World J Gastroenterol; 2007 Mar; 13(10):1528-33. PubMed ID: 17461444
[TBL] [Abstract][Full Text] [Related]
19. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
20. Hypermethylated DNA, a circulating biomarker for colorectal cancer detection.
Rasmussen SL; Krarup HB; Sunesen KG; Johansen MB; Stender MT; Pedersen IS; Madsen PH; Thorlacius-Ussing O
PLoS One; 2017; 12(7):e0180809. PubMed ID: 28700744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
